Black Rock Inc. Phathom Pharmaceuticals, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PHAT
# of Institutions
145Shares Held
59.4MCall Options Held
94KPut Options Held
55.5K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$84.7 Million3.99% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$62.6 Million20.28% of portfolio
-
Invesco Ltd. Atlanta, GA3.65MShares$30.6 Million0.0% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$29.3 Million27.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.78MShares$23.3 Million0.0% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $328M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...